These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 619893

  • 1. Further studies on the inhibition of monoamine oxidation by monoamine oxidase inhibitors.
    Ghosh SK, Guha SR.
    Biochem Pharmacol; 1978 Jan 01; 27(1):112-4. PubMed ID: 619893
    [No Abstract] [Full Text] [Related]

  • 2. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA, Kalnina IE, Moskvitina TA, Gorkin VZ.
    Biochem Pharmacol; 1977 Jun 01; 26(11):1059-63. PubMed ID: 18152
    [No Abstract] [Full Text] [Related]

  • 3. [The significance of amine oxidases in pathological states].
    Gorkin VZ.
    Patol Fiziol Eksp Ter; 1988 Jun 01; (2):89-92. PubMed ID: 3137516
    [No Abstract] [Full Text] [Related]

  • 4. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA, Feor K.
    Biochem Pharmacol; 1978 Jun 01; 27(11):1606-8. PubMed ID: 697902
    [No Abstract] [Full Text] [Related]

  • 5. Amine oxidases in apoptosis and cancer.
    Toninello A, Pietrangeli P, De Marchi U, Salvi M, Mondovì B.
    Biochim Biophys Acta; 2006 Jan 01; 1765(1):1-13. PubMed ID: 16225993
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of monoamine oxidase activity in mouse brain.
    Hall TR, Figueroa HR.
    Pharmacol Res Commun; 1982 May 01; 14(5):431-41. PubMed ID: 7111359
    [No Abstract] [Full Text] [Related]

  • 7. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT, Mozayani A, Danielson TJ, Baker GB.
    J Pharm Sci; 1991 Aug 01; 80(8):765-7. PubMed ID: 1791538
    [Abstract] [Full Text] [Related]

  • 8. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS, Campbell IC, Walker M, Statham NJ, Lovenberg W, Murphy DL.
    Neuropharmacology; 1979 Oct 01; 18(10):771-6. PubMed ID: 42024
    [No Abstract] [Full Text] [Related]

  • 9. Amine competition for oxidation by rat liver mitochondrial monoamine oxidase.
    Houslay MD, Tipton KF.
    Biochem Pharmacol; 1975 Mar 01; 24(5):627-31. PubMed ID: 1125064
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism of acetylpolyamines by monoamine oxidase, diamine oxidase and polyamine oxidase.
    Suzuki O, Matsumoto T, Oya M, Katsumata Y.
    Biochim Biophys Acta; 1981 Oct 12; 677(2):190-3. PubMed ID: 6794648
    [Abstract] [Full Text] [Related]

  • 11. [Oxidative deamination data on biogenic monoamines in the mitochondrial fraction of rat brain and liver].
    Sarukhanian ZhG, Babaian EA, Darbinian GV.
    Gig Tr Prof Zabol; 1981 Apr 12; (4):30-3. PubMed ID: 7239268
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in kinetics of deaminated biogenic amines in spontaneous hypertension].
    Ioffina DI, Smirnov IE, Gorkin VZ.
    Vopr Med Khim; 1991 Apr 12; 37(1):59-63. PubMed ID: 1858344
    [Abstract] [Full Text] [Related]

  • 17. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
    Lake BG, Harris RA, Collins MA, Cottrell RC, Phillips JC, Gangolli SD.
    Xenobiotica; 1982 Sep 12; 12(9):567-79. PubMed ID: 6818776
    [Abstract] [Full Text] [Related]

  • 18. [Monoamine oxidase activity and the content of biogenic amines in the brain under the action of haloperidol].
    Dovedova EL.
    Nerv Sist; 1991 Sep 12; 30():134-40. PubMed ID: 1817229
    [No Abstract] [Full Text] [Related]

  • 19. Serum prolactin and brain and pituitary monoamine responses to chronic monoamine oxidase inhibition in the rat.
    Smythe GA, Brandstater JF.
    Aust J Biol Sci; 1979 Dec 12; 32(6):543-7. PubMed ID: 317700
    [Abstract] [Full Text] [Related]

  • 20. The rational design of suicide substrates of amine oxidases.
    Palfreyman MG, McDonald IA, Bey P, Danzin C, Zreika M, Lyles GA, Fozard JR.
    Biochem Soc Trans; 1986 Apr 12; 14(2):410-3. PubMed ID: 3086155
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.